CPhO's Clinical Fellow Scheme: Applications now open
The Chief Pharmaceutical Officer's Clinical Fellow Scheme for 2020/21 is seeking applications to commence in posts from September 2020. The Scheme provides opportunities for pharmacists to spend (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 27, 2020 Category: Drugs & Pharmacology Source Type: news

Novel coronavirus: Updated advice for the NHS in England
The Chief Medical Officer for England has issued an updated Message for all clinical staff encountering patients with respiratory infections arrived from overseas. The letter and guidance can be acce (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 27, 2020 Category: Drugs & Pharmacology Source Type: news

Supply Disruption Alert - Epanutin ® (phenytoin) 30mg/5ml Oral Suspension
The Department of Health and Social Care (DHSC) have issued a Supply Disruption Alert for... Epanutin® (phenytoin) 30mg/5ml oral suspension, which will be out of stock from w/c 2nd March until lat (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 27, 2020 Category: Drugs & Pharmacology Source Type: news

Aubagio (teriflunomide)
Title: Aubagio (teriflunomide)Category: MedicationsCreated: 2/27/2020 12:00:00 AMLast Editorial Review: 2/27/2020 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - February 27, 2020 Category: Drugs & Pharmacology Source Type: news

Anjeso (Meloxicam Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 27, 2020 Category: Drugs & Pharmacology Source Type: news

Twirla (Levonorgestrel and Ethinyl Estradiol Transdermal System) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 27, 2020 Category: Drugs & Pharmacology Source Type: news

Nexletol (Bempedoic Acid Tablets, for Oral Use) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 27, 2020 Category: Drugs & Pharmacology Source Type: news

FDA Approves Barhemsys (amisulpride) for the Treatment and Prevention of PONV
Cambridge, UK and Indianapolis, US– 27 February 2020: Acacia Pharma Group plc (“Acacia Pharma” or the“Company”) (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialization of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 27, 2020 Category: Drugs & Pharmacology Source Type: news

FDA Approves Barhemsys (amisulpride) for the Treatment and Prevention of Postoperative Nausea and Vomiting
Cambridge, UK and Indianapolis, US– 27 February 2020: Acacia Pharma Group plc (“Acacia Pharma” or the“Company”) (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialization of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 27, 2020 Category: Drugs & Pharmacology Source Type: news

FDA D.I.S.C.O.: A new drug approval for IDH1 positive relapsed or refractory Acute Myeloid Leukemia
FDA medical oncologists discuss the July 2018 approval of ivosidenib for the treatment of patients with relapsed or refractory acute myeloid leukemia (AML) with a susceptible IDH1 mutation as detected by an FDA-approved test. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 27, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Approves Nexlizet (bempedoic acid and ezetimibe) to Lower LDL-Cholesterol
ANN ARBOR, Mich., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced that the U.S. Food and Drug Administration (FDA) approved Nexlizet (bempedoic acid and ezetimibe) tablet, an oral, once-daily, non-statin LDL-Cholesterol... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 26, 2020 Category: Drugs & Pharmacology Source Type: news

Droperidol Resurfaces After Mysterious Disappearance Droperidol Resurfaces After Mysterious Disappearance
After being banished for 20 years, droperidol is back on the market — and doctors are ready to embrace it.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 26, 2020 Category: Drugs & Pharmacology Tags: Emergency Medicine News Source Type: news

Puma Biotechnology Receives U.S. FDA Approval of Supplemental New Drug Application for Neratinib to Treat HER2-Positive Metastatic Breast Cancer
LOS ANGELES, Calif., Feb. 26, 2020 - Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) for neratinib in combination... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 26, 2020 Category: Drugs & Pharmacology Source Type: news

FDA approves neratinib for metastatic HER2-positive breast cancer
Oncology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 26, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Novel coronavirus: Updated advice for the NHS in Wales
The Chief Medical Officer for Wales has issued an updated advice for returning travellers as a result of the increase in cases of coronavirus (COVID-19) in a number of countries including Italy. The c (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 26, 2020 Category: Drugs & Pharmacology Source Type: news

Supply Disruption Alert - Diamorphine Hydrochloride powder for reconstitution and injection 5mg & 10mg ampoules
The Department of Health and Social Care (DHSC) has issued a supply disruption alert.. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 26, 2020 Category: Drugs & Pharmacology Source Type: news

RPS pledges “Time to change”
RPS Chief Executive Paul Bennett has signed the Time to Change pledge, committing the organisation to reducing discrimination around mental health in the workplace and changing the way employers think (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 26, 2020 Category: Drugs & Pharmacology Source Type: news

Risk of Adverse Pregnancy-related Outcomes in IBD Risk of Adverse Pregnancy-related Outcomes in IBD
Do patients with inflammatory bowel disease have an increased risk of adverse maternal, placental, or obstetric-related pregnancy outcomes?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 26, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Anjeso (Meloxicam Injection) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 26, 2020 Category: Drugs & Pharmacology Source Type: news

Twirla (Levonorgestrel and Ethinyl Estradiol Transdermal System) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 26, 2020 Category: Drugs & Pharmacology Source Type: news

Nexletol (Bempedoic Acid Tablets, for Oral Use) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 26, 2020 Category: Drugs & Pharmacology Source Type: news

FDA D.I.S.C.O.: FDA approval of moxetumomab pasudotox-tdfk for relapsed or refractory hairy cell leukemia
FDA medical oncologists discuss the Sept. 13, 2018, approval of moxetumomab pasudotox-tdfk for the treatment of patients with relapsed or refractory hairy cell leukemia (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 25, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA D.I.S.C.O.: FDA approval of larotrectinib for advanced malignancies with NTRK gene fusion
FDA medical oncologists discuss the accelerated approval of larotrectinib for adult and pediatric patients with solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 25, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA D.I.S.C.O.: FDA approval of cemiplimab-rwlc for cutaneous squamous cell carcinoma
FDA medical oncologists discuss the September 28, 2018, approval of cemiplimab-rwlc for the treatment of select patients with cutaneous squamous cell carcinoma. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 25, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Up Inya Gear - 553138 - 06/04/2019
New Drug/Misbranded (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 25, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

COVID-19 (coronavirus) – guidance for returning travellers and visitors arriving in the UK
Public Health England has issued guidance for people returning to the UK and visitors arriving in the UK from specified countries and areas. For more details see the Public Health England guidance. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 25, 2020 Category: Drugs & Pharmacology Source Type: news

TSDR Pharmacy Inc. dba brandMD Skin Care - 540960 - 04/29/2019
Compounding Pharmacy/Adulterated Drug Products, TSDR Pharmacy Inc. dba brandMD Skin Care (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 25, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Stonegate Pharmacy LP - 505526 - 04/24/2019
Compounding Pharmacy/Adulteration/Misbranding, Stonegate Pharmacy LP (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 25, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

COVID-19 (coronavirus) – guidance for returning travellers and visitors arriving in the UK
Public Health England has issued guidance for people returning to the UK and visitors arriving in the UK from specified countries and areas. For more details see the Public Health England guidance. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 25, 2020 Category: Drugs & Pharmacology Source Type: news

The FDA Supports Research to Reduce Health Disparities
Scientific researchers now are working on how to reduce health disparities (differences in health outcomes) among racial and ethnic minorities. And they're doing it with the help of funding from--and by working with--the U.S. Food and Drug Administration. Learn more. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 25, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Prescription Charges - We talk to BBC Radio 4 programme
RPS President Sandra Gidley was interviewed as part of an episode on BBC Radio 4’s My Name Is… programme, the episode called Joanna: Can’t Afford My Medication. The programme focus (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 25, 2020 Category: Drugs & Pharmacology Source Type: news

Essnd Global - 595850 - 02/14/2020
CGMP/Finished Pharmaceuticals/Adulterated (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 25, 2020 Category: Drugs & Pharmacology Authors: Center for Drug Evaluation and Research Source Type: news

Yibin Lihao Bio-technical Co., Ltd. - 592503 - 02/13/2020
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 25, 2020 Category: Drugs & Pharmacology Authors: Center for Drug Evaluation and Research Source Type: news

LeeSar, Inc. - 544728 - 02/18/2020
CGMP/Drug Products/Adulterated (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 25, 2020 Category: Drugs & Pharmacology Authors: Office of Pharmaceutical Quality Operations, Division II Source Type: news

KVK-Tech, Inc - 592387 - 02/11/2020
CGMP/Finished Pharmaceuticals/Adulterated (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 25, 2020 Category: Drugs & Pharmacology Authors: Office of Pharmaceutical Quality Operations, Division I Source Type: news

JHS Svendgaard Hygiene Products Ltd - 593473 - 02/13/2020
CGMP/Finished Pharmaceuticals/Adulterated (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 25, 2020 Category: Drugs & Pharmacology Authors: Center for Drug Evaluation and Research Source Type: news

Class 4 Medicines Defect Information: Memantine 10mg Film-Coated Tablets, PL 20416/0260
Crescent Pharma Ltd has informed the Medicines and Healthcare products Regulatory Agency (MHRA) of... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 25, 2020 Category: Drugs & Pharmacology Source Type: news

Rico-Perez Products, Inc. - 547180 - 05/18/2018
Labeling/False& Misleading Claims/Misbranded (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 25, 2020 Category: Drugs & Pharmacology Authors: Center for Food Safety and Applied Nutrition Source Type: news

Anoro Ellipta (umeclidinium and vilanterol)
Title: Anoro Ellipta (umeclidinium and vilanterol)Category: MedicationsCreated: 2/25/2020 12:00:00 AMLast Editorial Review: 2/25/2020 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - February 25, 2020 Category: Drugs & Pharmacology Source Type: news

Good Laboratory Practice Regulations Management Briefings, Post Conference Report, Aug 1979
Guidance for Industry, Good Laboratory Practice Regulations Management Briefings, Post Conference Report, Aug 1979 (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 25, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA approves first generic of ProAir HFA
FDA has approved an application for the first generic of ProAir HFA (albuterol sulfate) Inhalation Aerosol. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 24, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Remarks by Dr. Hahn to the Public Meeting on Rare Diseases - 02/24/2020 -
Remarks by Dr. Hahn to the Public Meeting on Rare Diseases (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 24, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Real World Evidence - From Safety to a Potential Tool for Advancing Innovative Ways to Develop New Medical Therapies
Real World Evidence --- From Safety to a Potential Tool for Advancing Innovative Ways to Develop New Medical Therapies with Jacqueline Corrigan-Curay and David Martin (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 24, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Risk of Relapse Among Patients With UC in Endoscopic Remission Risk of Relapse Among Patients With UC in Endoscopic Remission
This study aimed to quantify the association between histologic activity and clinical relapse among patients with ulcerative colitis who were in complete endoscopic remission.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 24, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Therapeutic Biologics Applications (BLA)
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 24, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Resources for Information | Approved Drugs
FDA provides online resources for information on approved drugs for consumers and health care professionals--including links to Orange Book and Drugs@FDA. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 24, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Medicine Supply Notification - Lorazepam (Ativan) 4mg/ml injection (tier 2), Penicillamine 125mg and 250mg tablets (tier 2) and an update on resupply dates
The Department of Health and Social Care (DHSC) has issued twoMedicine Supply Notifications. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 24, 2020 Category: Drugs & Pharmacology Source Type: news

Background Information: Lists of Licensed Biological Products with Reference Product Exclusivity and Biosimilarity or Interchangeability Evaluations (Purple Book)
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 24, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

RPS responds to Community Pharmacy Contractual Framework funding update
Funding for the Community Pharmacy Contractual Framework (CPCF) has been announced for the year 2020/21, in line with the five-year settlement. The deal, which was established in 2019, was agreed bet (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 24, 2020 Category: Drugs & Pharmacology Source Type: news

2018 Meeting Materials, Pulmonary-Allergy Drugs Advisory Committee
Meeting materials for the Pulmonary-Allergy Drugs Advisory Committee meetings for 2018, including the meeting announcement, briefing materials, committee roster, webcast information, agenda, committee questions, meeting roster, presentation slides, summary minutes, and transcript. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 24, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news